AGP Executive Report
Last update: 9 hours agoRegulatory Watch: The FDA granted fast-track status to SOT106, an investigational antibody-drug conjugate for soft tissue sarcoma, aiming to speed development for a hard-to-treat cancer. Health Policy & Access: A new report says a contractor filed $1.6B in improper school Medicaid claims, raising questions about how billing estimates were produced. Medicare Costs: Many retirees face higher Medicare premiums via IRMAA surcharges; guidance highlights how to appeal and lower what you pay. Clinical Care Trends: Aesthetic medicine is shifting toward regenerative approaches that focus on helping skin repair itself, not just surface fixes. Public Health & Safety: Kentucky’s medical cannabis rollout hit a milestone as the 24th licensed dispensary opened, reaching half of authorized sites. Global Health: An Israeli strike damaged a Gaza hospital medicine storage facility, worsening already severe supply shortages. Legal Accountability: The UN court in The Hague rejected claims that Ratko Mladic didn’t receive proper medical care before his death, saying treatment met international standards.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
